Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Antidilutive Shares (Details)

v3.23.2
Net Loss Per Share - Schedule of Antidilutive Shares (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jan. 11, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Capped Call Transactions          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Proceeds from convertible debt $ 29.3        
Offering price per share (in dollars per share)   $ 85.75   $ 85.75  
2025 Convertible Notes | Convertible Debt          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Convertible notes, conversion price (in dollars per share)   16.07   16.07  
2028 Convertible Notes | Convertible Debt          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Convertible notes, conversion price (in dollars per share)   $ 16.07   $ 16.07  
Stock options          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities (in shares)   574,000 68,000 474,000 332,000
Restricted stock awards          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities (in shares)   1,016,000 52,000 987,000 152,000
Convertible Debt Securities | 2025 Convertible Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities (in shares)   5,538,000 5,538,000 5,538,000 5,538,000
Convertible Debt Securities | 2028 Convertible Notes          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities (in shares)   5,215,000 5,215,000 5,215,000 5,215,000